Input 2021.03.03 18:27
Prime Minister Jeong Sye-gyun said on the 3rd to Na Seong-woong, deputy chief of the Centers for Disease Control and Prevention, “think of using (Pungrim) Pharmatech (syringe) a little more. Then Na replied, “That’s less air. I’ll review it right away.” However, the government admits that this syringe is of excellent quality, but did not purchase it because it signed a contract to supply the least residual type (LDS) vaccine syringe from another domestic company.
–
–
The quarantine authorities explained that the reason for not securing Poonglim Pharmatech syringes was that they had contracted products from other companies first. At a briefing on the 20th of last month, “We signed a contract to supply syringes with two domestic companies on January 26th,” said Yang Donggyo, head of the support management team of the Corona 19 Vaccination Response Promotion Team. “The syringe mass production system was not equipped.”
Prime Minister Chung said on the day that the Korea Centers for Disease Control and Prevention was able to increase the number of inoculations with the remaining amount from the use of LDS syringes. Take action to get more vaccinations.”
Prime Minister Jung said, “The result of inoculating more people with the same amount of vaccine is confirmed by the combination of the syringe made by our company and the delicate hands of the nurses.” (Residual dose additional vaccination) should not put a burden on the medical staff,” he said. “In any case, it should not be unreasonable or cause side effects, or stress on the medical staff.”
–
– .
